Marta Valenza, PharmD, PhD
Postdoctoral Fellow (previously held)
Boston University Chobanian & Avedisian School of Medicine

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Bonifacino T, Mingardi J, Facchinetti R, Sala N, Frumento G, Ndoj E, Valenza M, Paoli C, Ieraci A, Torazza C, Balbi M, Guerinoni M, Muhammad N, Russo I, Milanese M, Scuderi C, Barbon A, Steardo L, Bonanno G, Popoli M, Musazzi L. Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress. Transl Psychiatry. 2023 Feb 18; 13(1):62. PMID: 36806044; PMCID: PMC9938874; DOI: 10.1038/s41398-023-02366-w;
  2. Valenza M, Scuderi C. How useful are biomarkers for the diagnosis of Alzheimer's disease and especially for its therapy? Neural Regen Res. 2022 Oct; 17(10):2205-2207. PMID: 35259832; PMCID: PMC9083181; DOI: 10.4103/1673-5374.335791;
  3. Valenza M, Facchinetti R, Steardo L, Scuderi C. Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications. Biomolecules. 2022 Aug 27; 12(9). PMID: 36139030; PMCID: PMC9496237; DOI: 10.3390/biom12091191;
  4. Facchinetti R, Valenza M, Gomiero C, Mancini GF, Steardo L, Campolongo P, Scuderi C. Co-Ultramicronized Palmitoylethanolamide/Luteolin Restores Oligodendrocyte Homeostasis via Peroxisome Proliferator-Activated Receptor-a in an In Vitro Model of Alzheimer's Disease. Biomedicines. 2022 May 26; 10(6). PMID: 35740258; PMCID: PMC9219769; DOI: 10.3390/biomedicines10061236;
  5. Valenza M, Steardo L, Steardo L, Verkhratsky A, Scuderi C. Systemic Inflammation and Astrocyte Reactivity in the Neuropsychiatric Sequelae of COVID-19: Focus on Autism Spectrum Disorders. Front Cell Neurosci. 2021; 15:748136. PMID: 34912192; PMCID: PMC8666426; DOI: 10.3389/fncel.2021.748136;
  6. Friuli M, Eramo B, Valenza M, Scuderi C, Provensi G, Romano A. Targeting the Oxytocinergic System: A Possible Pharmacological Strategy for the Treatment of Inflammation Occurring in Different Chronic Diseases. Int J Mol Sci. 2021 Sep 23; 22(19). PMID: 34638587; PMCID: PMC8508899; DOI: 10.3390/ijms221910250;
  7. Valenza M, Facchinetti R, Menegoni G, Steardo L, Scuderi C. Alternative Targets to Fight Alzheimer's Disease: Focus on Astrocytes. Biomolecules. 2021 04 19; 11(4). PMID: 33921556; PMCID: PMC8073475; DOI: 10.3390/biom11040600;
  8. Facchinetti R, Valenza M, Bronzuoli MR, Menegoni G, Ratano P, Steardo L, Campolongo P, Scuderi C. Looking for a Treatment for the Early Stage of Alzheimer's Disease: Preclinical Evidence with Co-Ultramicronized Palmitoylethanolamide and Luteolin. Int J Mol Sci. 2020 May 27; 21(11). PMID: 32471239; PMCID: PMC7312730; DOI: 10.3390/ijms21113802;
  9. Valenza M, Blasio A, DiLeo A, Cottone P, Sabino V. Sigma receptor-induced heavy drinking in rats: Modulation by the opioid receptor system. Pharmacol Biochem Behav. 2020 05; 192:172914.View Related Profiles. PMID: 32205151; PMCID: PMC9551643; DOI: 10.1016/j.pbb.2020.172914;
  10. Valenza M, Facchinetti R, Steardo L, Scuderi C. Altered Waste Disposal System in Aging and Alzheimer's Disease: Focus on Astrocytic Aquaporin-4. Front Pharmacol. 2019; 10:1656. PMID: 32063858; PMCID: PMC7000422; DOI: 10.3389/fphar.2019.01656;
Showing 10 of 27 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 27 publications over 12 distinct years, with a maximum of 5 publications in 2015


Contact for Mentoring:

72 E. Concord St Silvio Conte (K)
Boston MA 02118
Google Map

Valenza's Networks
Click the "See All" links for more information and interactive visualizations
Similar People